Clinical Trial: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: IgA Nephropathy (IgAN)
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, and Placebo-controlled Parallel Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK39297 Tablets in Treatment of Patients With Primary IgAN
Brief Summary:
Evaluate the efficacy and safety of HSK39297 tablets in patients with primary IgAN
Read more